$1M Bet On Lyft? Check Out These 4 Stocks Insiders Are Buying
Portfolio Pulse from Lisa Levin
Insiders at Asana, Medalist Diversified REIT, Lyft, and Insulet have recently made notable purchases of their companies' stocks. Asana's CEO acquired 160,000 shares, Medalist Diversified REIT's Director bought 4,826 shares, Lyft's Director purchased 96,900 shares, and Insulet's CEO bought 5,550 shares. These purchases may indicate the insiders' confidence in their companies' prospects.
August 30, 2023 | 1:28 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Asana's CEO purchased 160,000 shares, indicating confidence in the company's prospects. This follows Asana's announcement of new product capabilities.
Insider purchases often indicate confidence in a company's prospects. Asana's CEO's purchase, coupled with the company's announcement of new product capabilities, suggests a positive outlook.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Lyft's Director purchased 96,900 shares, potentially indicating confidence in the company's prospects. This follows Lyft's Q2 revenue report, which was in line with Street consensus estimates.
The Director's purchase of shares, along with Lyft's Q2 revenue report, suggests a positive outlook for the company.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Medalist Diversified REIT's Director purchased 4,826 shares, potentially signaling confidence in the company's prospects. This follows the company's approval of the sale of interests in four properties.
The Director's purchase of shares, along with the company's recent approval of property sales, suggests a positive outlook for Medalist Diversified REIT.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Insulet's CEO purchased 5,550 shares, potentially indicating confidence in the company's prospects. This follows Insulet's commercial launch of its Omnipod 5 automated insulin delivery system in Germany.
The CEO's purchase of shares, along with the company's product launch in Germany, suggests a positive outlook for Insulet.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100